The above article was sent to subscribers in Pharmacy Daily's issue from 21 Jul 11
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jul 11
THE Australian Government and Advanced Pharmacy Australia (AdPha) have broadly welcomed and endorsed the World Health Organization’s (WHO) new Pandemic Agreement, which lays out a coordinated global response against future outbreaks.
THE Therapeutic Goods Administration (TGA) has registered Kisunla (donanemab, Eli Lilly) for the treatment of adults with early symptomatic Alzheimer’s disease who have a specific genetic profile and the confirmed presence of amyloid plaque in the brain.
IN partnership with CARMEX
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.
Notifications